Drugs News and Research

RSS

Researchers develop new method for drug discovery using math to combat HIV, other diseases

Using mathematical concepts, Princeton researchers have developed a method of discovering new drugs for a range of diseases by calculating which physical properties of biological molecules may predict their effectiveness as medicines.

8 Feb 2011

Study reports significant decline in second-generation medication use for dementia

As loved ones with dementia disappear into symptoms of aggression, agitation or delusions, families are left with few good medical solutions. A new generation of antipsychotic medications gained popularly in the 1990s because they avoided side effects such as Parkinson's syndrome associated with conventional antipsychotic medications used to treat dementia.

8 Feb 2011

Study: Cannabis use appears to be linked with earlier onset of psychotic illness

Cannabis use appears to be associated with an earlier onset of psychotic illness, according to a meta-analysis of previously published studies posted online today that will appear in the June print issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

8 Feb 2011

Tufts announces public launch of Institute for Biomedical Partnerships, HUB website

Tufts University today announced the public launch of the Tufts Institute for Biomedical Partnerships website/HUB: www.tuftspharmapartners.org.

8 Feb 2011

Researchers identify CHK1 protein may serve as treatment target for neuroblastoma

After analyzing hundreds of proteins produced by the DNA of tumor cells, researchers have identified one protein that may be central to a new treatment for the often-fatal childhood cancer neuroblastoma. Oncologists hope to translate the finding into pediatric clinical trials of a drug that blocks the protein's activity.

7 Feb 2011

Harbor BioSciences closes U.S.-based Apoptone Phase I/IIa clinical trial for castration resistant prostate cancer

Harbor BioSciences, Inc., a biopharmaceutical company developing novel therapeutics for the treatment of cancer, metabolic and inflammatory diseases, today announced it is closing the clinical sites of its U.S.-based Phase I/IIa clinical trial with Apoptone® (HE3235) for castration resistant prostate cancer (CRPC) – also referred to as hormone resistant prostate cancer.

7 Feb 2011

AMRI fourth quarter total revenue increases 12% to $48.6 million

AMRI today reported financial and operating results for the fourth quarter and full year ended December 31, 2010.

7 Feb 2011

BAI releases 2011 State of AIDS in Black America report

The Black AIDS Institute ("BAI"), the only national HIV/AIDS think tank focused exclusively on the Black community in the US, today released its 2011 State of AIDS in Black America report, Deciding Moment. 2011 marks the 30th anniversary of the AIDS epidemic in America and presents unique opportunities to curtail the HIV/AIDS pandemic, but key challenges remain to moving forward in the AIDS response in Black America.

7 Feb 2011

The Lancet journal publishes BENLYSTA BLISS-52 study against SLE

Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced publication of the BLISS-52 study of BENLYSTA in autoantibody-positive patients with active systemic lupus erythematosus in The Lancet.

7 Feb 2011

Positive results from EpiCept NP-1 Phase IIb trial in patients with CPN

EpiCept Corporation today announced positive results from a Phase IIb trial evaluating the efficacy and safety of EpiCept NP-1 in chemotherapy-induced peripheral neuropathy. EpiCept NP-1 is a topical analgesic cream containing two FDA-approved drugs, amitriptyline and ketamine, in development for the relief of pain from various peripheral neuropathies.

7 Feb 2011

Pediatric physicians present 12 research abstracts, posters at Cardiology 2011

Pediatric cardiology researchers and clinicians gather this week in Scottsdale, Ariz. for Cardiology 2011, the 15th Annual Update on Pediatric and Congenital Cardiovascular Disease, sponsored by The Children's Hospital of Philadelphia. Original research from more than 30 cardiac programs in the U.S. and abroad is being presented throughout the meeting.

7 Feb 2011

Technique that cleared mouse of HIV-like virus sparks hope for new therapy

In a breakthrough, Australian researchers have developed a method to boost the immune system. This technique is seen to be capable of clearing an “HIV-like” infection from a mouse. This could in future lead to a cure for HIV and other chronic viral infections in humans. The findings from Melbourne’s Walter and Eliza Hall Institute are centred on a naturally occurring cell signalling hormone called interleukin-7 (IL-7).

6 Feb 2011

Radical regulatory reform for life science industries needs to be a priority: Researchers

This declining trend is blamed on a failure of innovative drive in the industry, failure of the UK to support basic research, failure of venture capital to invest in early stage research, or failure of the Health Service to provide smart procurement.

5 Feb 2011

FDA approves Makena injection to reduce risk of preterm delivery

The U.S. Food and Drug Administration today approved Makena (hydroxyprogesterone caproate) injection to reduce the risk of preterm delivery before 37 weeks of pregnancy, in pregnant women with a history of at least one spontaneous preterm birth.

5 Feb 2011

Maxygen distributes Codexis's shares to its stockholders for U.S. Federal income tax purposes

Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its distributions of Codexis, Inc. common stock and cash in December 2010 will be classified as a return of capital to its stockholders for U.S. Federal income tax purposes.

5 Feb 2011

Mental health, substance abuse spending grew more slowly than all other health spending: Study

Spending on psychiatric drugs grew by 5.6 percent from 2004 to 2005, down from the 27.3 percent growth from 1999 to 2000 according to a study published today in the February issue of Health Affairs.

5 Feb 2011

Palomar Medical Technologies to launch Acleara acne clearing system at AAD meeting

Palomar Medical Technologies, Inc., a leading researcher and developer of light-based systems for cosmetic treatments, announced today the launch of the Acleara acne clearing system at the 69th Annual Meeting of the American Academy of Dermatology in New Orleans, Louisiana, from February 5th through February 7th.

5 Feb 2011

Patients receiving cancer treatment may experience skin, hair, nail problems

A cancer diagnosis and subsequent treatment, which commonly includes chemotherapy or radiation, can be taxing physically and emotionally on any patient. If that is not enough, dermatologists are cautioning patients receiving cancer treatment and cancer survivors that they may experience a host of skin, hair or nail problems as a direct result of their therapy that may require additional treatment by a dermatologist.

5 Feb 2011

Lotus adds two additional stories to new Beijing headquarters building

Lotus Pharmaceuticals, Inc., a fast-growing, profitable developer, manufacturer and seller of medicine and drugs in the People's Republic of China ("PRC"), today announced that it will add two additional stories to its new headquarters building in Chaoyang District, Beijing, which is currently under construction and is scheduled to be completed in the second quarter of 2011.

5 Feb 2011

Anti-cancer drug tied to golden missiles

Researchers at Case Western Reserve University have developed a little bomb that promises a big bang for cancer patients.

5 Feb 2011

Drugs News and Research

Researchers develop new method for drug discovery using math to combat HIV, other diseases

Study reports significant decline in second-generation medication use for dementia

Study: Cannabis use appears to be linked with earlier onset of psychotic illness

Tufts announces public launch of Institute for Biomedical Partnerships, HUB website

Researchers identify CHK1 protein may serve as treatment target for neuroblastoma

Harbor BioSciences closes U.S.-based Apoptone Phase I/IIa clinical trial for castration resistant prostate cancer

AMRI fourth quarter total revenue increases 12% to $48.6 million

BAI releases 2011 State of AIDS in Black America report

The Lancet journal publishes BENLYSTA BLISS-52 study against SLE

Positive results from EpiCept NP-1 Phase IIb trial in patients with CPN

Pediatric physicians present 12 research abstracts, posters at Cardiology 2011

Technique that cleared mouse of HIV-like virus sparks hope for new therapy

Radical regulatory reform for life science industries needs to be a priority: Researchers

FDA approves Makena injection to reduce risk of preterm delivery

Maxygen distributes Codexis's shares to its stockholders for U.S. Federal income tax purposes

Mental health, substance abuse spending grew more slowly than all other health spending: Study

Palomar Medical Technologies to launch Acleara acne clearing system at AAD meeting

Patients receiving cancer treatment may experience skin, hair, nail problems

Lotus adds two additional stories to new Beijing headquarters building

Anti-cancer drug tied to golden missiles

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News